These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 8639866)

  • 1. Safety of filtered leukocyte-reduced blood products for prevention of transfusion-associated cytomegalovirus infection.
    Landaw EM; Kanter M; Petz LD
    Blood; 1996 Jun; 87(11):4910. PubMed ID: 8639866
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of filtered leukocyte-reduced and cytomegalovirus (CMV) seronegative blood products for the prevention of transfusion-associated CMV infection after marrow transplant.
    Bowden RA; Slichter SJ; Sayers M; Weisdorf D; Cays M; Schoch G; Banaji M; Haake R; Welk K; Fisher L; McCullough J; Miller W
    Blood; 1995 Nov; 86(9):3598-603. PubMed ID: 7579469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Leukocyte depletion and infection by cytomegalovirus].
    Mazeron MC
    Transfus Clin Biol; 2000 Jun; 7 Suppl 1():31s-35s. PubMed ID: 10919221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indications for the use of cytomegalovirus-seronegative blood products.
    Preiksaitis JK
    Transfus Med Rev; 1991 Jan; 5(1):1-17. PubMed ID: 1666324
    [No Abstract]   [Full Text] [Related]  

  • 5. Transfusion-transmitted cytomegalovirus infection.
    Bowden RA
    Hematol Oncol Clin North Am; 1995 Feb; 9(1):155-66. PubMed ID: 7737939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group.
    Gilbert GL; Hayes K; Hudson IL; James J
    Lancet; 1989 Jun; 1(8649):1228-31. PubMed ID: 2566781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of transfusion-transmitted cytomegalovirus infection.
    Pamphilon DH; Rider JR; Barbara JA; Williamson LM
    Transfus Med; 1999 Jun; 9(2):115-23. PubMed ID: 10354380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of primary transfusion-associated cytomegalovirus infection in bone marrow transplant recipients by the removal of white cells from blood components with high-affinity filters.
    van Prooijen HC; Visser JJ; van Oostendorp WR; de Gast GC; Verdonck LF
    Br J Haematol; 1994 May; 87(1):144-7. PubMed ID: 7947238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfusion support using filtered unscreened blood products for cytomegalovirus-negative allogeneic marrow transplant recipients.
    Narvios AB; Przepiorka D; Tarrand J; Chan KW; Champlin R; Lichtiger B
    Bone Marrow Transplant; 1998 Sep; 22(6):575-7. PubMed ID: 9758346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological screening for the prevention of transfusion-acquired cytomegalovirus infection.
    Musiani M; Zerbini M; Carpi C; Plazzi M; Sermasi G; Belletti D; Sacchi R
    J Infect; 1984 Sep; 9(2):148-52. PubMed ID: 6094671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-related cytomegalovirus infection among very low birth weight infants in an endemic area.
    Kim AR; Lee YK; Kim KA; Chu YK; Baik BY; Kim ES; Yun SC; Kim KS; Pi SY
    J Korean Med Sci; 2006 Feb; 21(1):5-10. PubMed ID: 16479056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus studies on blood donors in north-east Scotland and a review of UK data.
    Galea G; Urbaniak SJ
    Vox Sang; 1993; 64(1):24-30. PubMed ID: 8383377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of leukoreduced, cytomegalovirus (CMV)-untested components in CMV-negative allogeneic human progenitor cell transplant recipients.
    Nash T; Hoffmann S; Butch S; Davenport R; Cooling L
    Transfusion; 2012 Oct; 52(10):2270-2. PubMed ID: 23110735
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevention of transfusion-acquired cytomegalovirus infection in infants.
    Hart S; Boughton BJ
    Lancet; 1989 Aug; 2(8661):502. PubMed ID: 2570207
    [No Abstract]   [Full Text] [Related]  

  • 15. Survey on Transfusion-Transmitted Cytomegalovirus and Cytomegalovirus Disease Mitigation.
    Weisberg SP; Staley EM; Williams LA; Pham HP; Bachegowda LS; Cheng YH; Schwartz J; Shaz BH
    Arch Pathol Lab Med; 2017 Dec; 141(12):1705-1711. PubMed ID: 28849943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the risk for transfusion-transmitted cytomegalovirus infection.
    Sayers MH; Anderson KC; Goodnough LT; Kurtz SR; Lane TA; Pisciotto P; Silberstein LE
    Ann Intern Med; 1992 Jan; 116(1):55-62. PubMed ID: 1309201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The need for prevention of post-transfusion cytomegalovirus infection in patients undergoing cardiac surgery.
    van Aken WG
    Eur Heart J; 1987 Apr; 8(4):382-3. PubMed ID: 3038553
    [No Abstract]   [Full Text] [Related]  

  • 18. The incidence and consequences of cytomegalovirus transmission via blood transfusion to low birth weight, premature infants in north east Scotland.
    Galea G; Urbaniak SJ
    Vox Sang; 1992; 62(4):200-7. PubMed ID: 1322610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Post-transfusion cytomegalovirus infections. The position in 1987].
    Andreu G; Bierling P; Brossard Y; Foucault C; Girard M; Gluckman E; Huart JJ; Janot C; Marinière AM; Mazeron MC
    Rev Fr Transfus Immunohematol; 1987 Nov; 30(4):331-6. PubMed ID: 2832928
    [No Abstract]   [Full Text] [Related]  

  • 20. Transfusion-associated cytomegalovirus infections.
    Adler SP
    Rev Infect Dis; 1983; 5(6):977-93. PubMed ID: 6318291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.